Treatment outcome of patients with unresectable stage III non-small cell lung cancer and interstitial pneumonia
ConclusionsCRT was the only predictive factor for longer survival in LC patients; however, no LC-IP patients received CRT, possibly because of the underlying IP.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Physiology | Pneumonia | Respiratory Medicine | Study | Women